EpiAgent: Foundation model for single-cell epigenomic data 
Xiaoyang Chen1, Keyi Li1, Xuejian Cui1, Zian Wang1, Qun Jiang1, Jiacheng Lin2, Zhen Li1, 
Zijing Gao1, Rui Jiang1,* 
 
1 Ministry of Education Key Laboratory of Bioinformatics, Bioinformatics Division at the Beijing 
National Research Center for Information Science and Technology, Center for Synthetic and Systems 
Biology, Department of Automation, Tsinghua University, Beijing 100084, China 
2 Department of Automation, Tsinghua University, Beijing 100084, China 
* To whom correspondence should be addressed. Email: ruijiang@tsinghua.edu.cn  
 
Abstract 
Large-scale foundation models have recently opened new avenues for artificial general 
intelligence. Such a research paradigm has recently shown considerable promise in the analysis of 
single-cell sequencing data, while to date, efforts have centered on transcriptome. In contrast to 
gene expression, chromatin accessibility provides more decisive insights into cell states, shaping 
the chromatin regulatory landscapes that control transcription in distinct cell types. Yet, challenges 
also persist due to the abundance of features, high data sparsity, and the quasi-binary nature of 
these data. Here, we introduce EpiAgent, the first foundation model for single-cell epigenomic 
data, pretrained on a large-scale Human-scATAC-Corpus comprising approximately 5 million 
cells and 35 billion tokens. EpiAgent encodes chromatin accessibility patterns of cells as concise 
"cell sentences," and employs bidirectional attention to capture cellular heterogeneity behind 
regulatory networks. With comprehensive benchmarks, we demonstrate that EpiAgent excels in 
typical downstream tasks, including unsupervised feature extraction, supervised cell annotation, 
and data imputation. By incorporating external embeddings, EpiAgent facilitates the prediction of 
cellular responses to both out-of-sample stimulated and unseen genetic perturbations, as well as 
reference data integration and query data mapping. By simulating the knockout of key 
cis-regulatory elements, EpiAgent enables in-silico treatment for cancer analysis. We further 
extended zero-shot capabilities of EpiAgent, allowing direct cell type annotation on newly 
sequenced datasets without additional training.  
 
Introduction 
Single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) captures 
chromatin dynamics and reveals regulatory landscapes at the level of individual cells1,2, enabling 
the detection of cell heterogeneity3, tissue development4, and disease mechanisms5. With advances 
in sequencing technologies, a multitude of large-scale cell atlases that encompass fetal 
development6, adult tissues7, brain tissues8, and neural development9 have been constructed, 
providing unprecedented resources to uncover regulatory patterns under diverse physiological 
conditions. However, the vast number of candidate cis-regulatory elements (cCREs), the extreme 
sparsity, and its quasi-binary nature pose significant challenges for scATAC-seq data analysis. 
Although numerous comprehensive pipelines10-13 and methods targeting specific tasks, such 
as unsupervised feature extraction14-18, supervised cell annotation19-21, and data imputation22,23, 
have been developed for scATAC-seq analysis, they still remain limited. First, most methods lack 
generalizability, being confined to solving single tasks with limited extensibility and requiring 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

major modifications to address new tasks. Second, they fail to effectively leverage the latent 
cellular heterogeneity and regulatory network information embedded in large-scale atlas-level 
datasets, often requiring retraining from scratch for new datasets and leading to unstable 
performance across different datasets. Third, they use high-dimensional cell-by-cCRE matrices 
as input, necessitating prior filtering that excludes many accessible cCREs, thereby compromising 
model performance. Finally, key challenges remain unaddressed, such as predicting cellular 
responses to external stimulation or genetic perturbations and simulating cell state changes 
following cCRE knockouts. Consequently, there is a pressing need for the foundation model and 
innovative pretraining strategies tailored to the unique characteristics of scATAC-seq data. 
 
Pretrained foundation models have emerged as a powerful paradigm in natural language 
processing24, computer vision25, and multimodal learning26, and are now becoming integral to the 
pursuit of artificial general intelligence27. Within single-cell sequencing, foundation models28-32 
have primarily been employed to simultaneously resolve cell representations and capture gene 
co-expression patterns in transcriptomic data33,34. In contrast, chromatin accessibility data contain 
more fundamental regulatory context that governs transcription, while developing a 
transformer-based foundation model to harness these data faces two major obstacles. First, the 
immense number of cCREs in total but few accessible in each cell, coupled with the values of 
quasi-binary nature, makes it challenging to formulate a cell sentence that meaningfully integrates 
these elements. Second, unlike words in a linguistic context, cCREs lack explicitly directional 
regulatory relationship, making traditional context-based pretraining strategies (e.g., masked 
language modeling or generative pretraining tasks) less directly applicable.  
Here we proposed EpiAgent, a transformer-based foundation model for single-cell 
epigenomic data. For providing comprehensive pretraining resources for EpiAgent, we 
constructed a large-scale corpus, Human-scATAC-Corpus, comprising approximately 5 million 
cells and 35 billion accessible cCREs. For each cell, EpiAgent considers only its accessible cCREs, 
ordering them by importance to form a cell sentence as input. EpiAgent has approximately 1.4 
billion parameters, including a cCRE embedding module, the EpiAgent transformer, and a signal 
decoder. EpiAgent is pretrained using a newly designed cell-cCRE alignment task, along with a 
signal reconstruction task, to learn fundamental patterns of cellular heterogeneity and regulatory 
networks by its bidirectional self-attention mechanism. 
To comprehensively evaluate EpiAgent, we first fine-tuned it on three typical downstream 
tasks, including unsupervised feature extraction, supervised cell annotation, and data imputation, 
and demonstrated its superior performance. Notably, when the dataset contains cell populations 
similar to Human-scATAC-Corpus, EpiAgent can directly produce cell embeddings rich in 
heterogeneity in zero-shot conditions. By incorporating perturbation-specific token embedding 
into the head token embedding, EpiAgent can accurately predict cellular responses to both 
out-of-sample stimulated and unseen genetic perturbations. By substituting external information 
with batch-specific token embeddings, EpiAgent effectively reduces or even eliminates batch 
effects when integrating data as a cell atlas. Using the cell atlas as reference, EpiAgent enables 
query data mapping with followed label transfer, outperforming the analysis of the query data 
alone. Benefiting from the unique modeling of cell sentences, EpiAgent enables flexible in-silico 
cCRE knockouts in cancer cells, facilitating the quantitative evaluation of their effects on cell 
states. To further extend zero-shot capabilities to cell type annotation, we developed EpiAgent-B 
and EpiAgent-NT, for directly annotating cells from brain and other tissues, respectively, without 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

requiring additional training. Together, EpiAgent represents a significant leap forward in 
single-cell epigenomic analysis, enabling more precise and comprehensive insights into cellular 
mechanisms. 
Results 
Overview of EpiAgent 
 
Fig. 1 | Overview of EpiAgent. a, Human-scATAC-Corpus, comprising approximately 5 million cells 
and 35 billion tokens from 31 tissues and 28 datasets, providing a valuable resource for pretraining 
EpiAgent. b, Tokenization in EpiAgent, where accessible cCREs in scATAC-seq data are ranked in 
descending order based on their TF-IDF-transformed values to form cell sentences. c, Model 
architecture of EpiAgent, consisting of three modules: (1) an embedding module, that converts cell 
sentences into embedding sequences, (2) the EpiAgent transformer, with multiple transformer blocks 
using bidirectional attention mechanisms to generate cell embeddings and contextual cCRE 
embeddings, and (3) a signal decoder that reconstructs signals from cell embeddings. d, Pretraining 
tasks for EpiAgent, including the cell-cCRE alignment task and the signal reconstruction task. 
EpiAgent is a transformer-based foundation model pretrained on our custom-built, large-scale 
scATAC-seq corpus, Human-scATAC-Corpus (Fig. 1a). Human-scATAC-Corpus comprises data 
from 31 different tissues, 28 public datasets, approximately 5 million cells, and 35 billion tokens, 
providing EpiAgent with diverse and comprehensive resources to learn general epigenetic 
regulatory patterns across various tissues and cell types during unsupervised pretraining.  
Due to the inherent high sparsity and dimensionality of scATAC-seq data, EpiAgent focuses 
on tokenizing only the cCREs that are accessible in cells. The ranks of tokens in a cell tokenized 
sentence are determined by the values after term frequency-inverse document frequency (TF-IDF) 
transformation (Fig. 1b).  
EpiAgent consists of three modules: an embedding module (~695 million parameters), the 
EpiAgent transformer (~57 million parameters), and a signal decoder (~695 million parameters), 
bringing the total parameter count to approximately 1.4 billion (Fig. 1c). A tokenized cell sentence 
is augmented with two special tokens, [CLS] (the classification token) and [SEP] (the separator 
token), at the beginning and end, respectively. The embedding module then converts the sentence 
into cCRE embeddings and rank embeddings, analogous to word embeddings and positional 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

embeddings in natural language processing. The EpiAgent transformer takes the sum of the two 
sets of embeddings as input, and uses the bidirectional attention mechanism to capture cCRE 
co-accessibility patterns, which can be regarded as regulatory networks at the chromatin level. The 
EpiAgent transformer consists of 18 layers of transformer encoder blocks, and outputs 
contextualized cCRE embeddings that corresponds directly to the input cCRE embeddings. Flash 
Attention v235 is also used for accelerating steps for training and inference. The output [CLS] 
embedding represents the cell embedding, and additional information can be introduced by adding 
a conditional embedding to the input [CLS] token embedding, allowing for in-silico simulation of 
changes in cell states. Finally, the signal decoder, consisting of a single-layer fully connected 
neural network, reconstructs the accessibility signal of all cCREs for each cell from the cell 
embeddings. 
The pretraining tasks for EpiAgent are designed to simultaneously capture cCRE 
co-accessibility patterns and generate comprehensive cell embeddings, encompassing two key 
tasks: the cell-cCRE alignment task and the signal reconstruction task (Fig. 1d). In the cell-cCRE 
alignment task, EpiAgent concatenates the output cell embedding with the input embeddings of 
cCREs that are either accessible or inaccessible in the cell, and performs a binary classification to 
determine their accessibility. In the signal reconstruction task, EpiAgent directly feeds the output 
cell embedding into the signal decoder to reconstruct the accessibility signals for all cCREs in the 
cell. After undergoing full pretraining on the Human-scATAC-Corpus, EpiAgent effectively 
captures cellular heterogeneity and regulatory networks across diverse tissues, sequencing 
technologies, and sequencing depths, achieving superior performance across a range of 
downstream tasks. The details regarding the Human-scATAC-Corpus, tokenization strategy, model 
architecture, and pretraining tasks are available in Methods. 
 
EpiAgent excels in typical downstream tasks of scATAC-seq data analysis 
Typical downstream analyses of single-cell data, including unsupervised feature extraction, 
supervised cell annotation, and data imputation, rely on accurate and robust computational 
frameworks36. As a foundation model for scATAC-seq data, EpiAgent serves as a core module that 
can be fine-tuned and integrated with task-specific modules to adapt to various downstream tasks 
(Fig. 2a). To comprehensively benchmark EpiAgent, we collected four additional datasets varying 
in similarity to Human-scATAC-Corpus: Buenrostro201837 (hematopoietic cell differentiation) , 
Kanemaru202338 (heart), Li2023b39 (brain), and Ameen202240 (stem cells cultured in vitro) 
datasets. Among these, Kanemaru2023 and Li2023b datasets, derived from human tissues, have 
similar cell populations with data in the Human-scATAC-Corpus, while Buenrostro2018 and 
Ameen2022 datasets contain cell types that differ significantly from those in the pretraining 
corpus.  
Unsupervised feature extraction. Given the high dimensionality and extreme sparsity of 
scATAC-seq data, direct analysis in the raw data space is infeasible, thus reducing scATAC-seq 
data to low-dimensional cell embeddings through feature extraction is a critical step. Using a 
strategy consistent with pretraining, we fine-tuned EpiAgent on new datasets and compared its 
zero-shot and fine-tuned performance against five baseline methods: cisTopic14, scBasset17, 
CASTLE18, SCALE15, and SCALEX16, with implementations followed open-source codes and 
default configurations. Notably, scBasset additionally incorporates cCRE sequence information, 
while other baselines rely solely on peak-by-cell matrices. Cell embeddings are clustered using the 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

Leiden algorithm, with the number of clusters aligned to the known cell types via a binary search 
approach. Clustering performance is evaluated using normalized mutual information (NMI) and 
adjusted Rand Index (ARI) scores, where higher values indicate embeddings that better capture 
cellular heterogeneity. Details on experimental setup, metric calculations, fine-tuning of EpiAgent, 
and baseline methods are provided in Methods. 
 
Fig. 2 | Typical downstream tasks of scATAC-seq data with EpiAgent. a, Overview of EpiAgent 
fine-tuned for various downstream tasks, including unsupervised feature extraction, supervised cell 
annotation, and data imputation. b, Benchmarking performance on unsupervised feature extraction 
evaluated by NMI and ARI scores. c, UMAP visualization of cell embeddings derived from the 
fine-tuned EpiAgent model compared to the second-best model, scBasset, on the Buenrostro2018 
dataset. d-g, Analysis of donor "BM0828" cells in the Buenrostro2018 dataset, including UMAP 
visualization of cell embeddings (d), PAGA trajectories (e), pseudo-time estimation (f), and the average 
pseudo-time of each cell type (g). UMAP visualizations (d-f), PAGA trajectories (e), and pseudo-time 
estimations (e & f) are derived from cell embeddings obtained using the fine-tuned EpiAgent model. 
Dashed lines in e indicate trajectories between sibling cell types. Pseudo-time (e & f) incorporates 
additional ClockDML information. h, Benchmarking performance on supervised cell type annotation 
evaluated by accuracy and macro F1 scores. i, Sankey plot among EpiAgent predicted labels, 
ground-truth labels and Cellcano (the second-best method) predicted labels on the Buenrostro2018 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

dataset. j, Benchmarking performance of data imputation evaluated by clustering metrics (NMI and 
ARI scores), and clustering is performed using PCA on imputed matrices from each method. k, Pearson 
correlation coefficients between imputed signals from each method and average raw signals of the 
corresponding cell types. l & m, Mean-square errors (l) and Pearson correlation coefficients (m) 
between imputed signals from each method and raw signals of their corresponding cell types for each 
method. In k-m, the upper, middle, and lower edges of the boxes denote the upper quartile, median, 
and lower quartile, respectively, and error bars denote the maximum and minimum values. 
 
As shown in Fig. 2b, the fine-tuned EpiAgent outperforms all baselines, with an average 
improvement of 7.214% and 25.975% in NMI and ARI, respectively, compared to the second-best 
model, cisTopic. On datasets with cell populations similar to those in the Human-scATAC-Corpus, 
EpiAgent performs competitively with baseline methods even without fine-tuning, particularly on 
the Li2023b dataset, owing to the brain cells constituting a substantial proportion of the 
pretraining data. UMAP visualizations (Fig. 2c and Supplementary Fig. 1-4) further illustrate that 
EpiAgent better separates distinct cell types and compresses intra-type variability, highlighting its 
ability to capture cellular heterogeneity. Such superiority stems from not only unique attention 
mechanism and pretraining strategy in the EpiAgent transformer to extract intrinsic information of 
cells, but also its modeling of cell sentences to focus on the widest possible range of accessible 
cCREs. In contrast, baseline methods relying on cell-by-cCRE matrices are inherently limited by 
extremely sparse signals and filtered cCREs. 
 
The cell embeddings derived from EpiAgent also reveal clear developmental trajectories. We 
first used the fine-tuned EpiAgent model to generate embeddings for cells of donor "BM0828" in 
the Buenrostro2018 dataset (Fig. 2g), and then performed PAGA to infer trajectories (Fig. 2e). 
Except for a few trajectories between sibling cell types (indicated by dashed lines), the inferred 
trajectories align well with hematopoietic differentiation. Furthermore, we combined clock-like 
differential methylation loci (ClockDML) identified by Xiao et al.41 with these embeddings to 
infer cellular pseudotime, which also can be served as relative mitotic age, without relying on 
inferred trajectories (Supplementary Note 1). As shown in Fig. 2f and Fig. 2g, EpiAgent 
accurately predicts pseudotime for hematopoietic differentiation, aligning well with the 
differentiation trajectories, while in contrast, the EpiTrace model41 mispredicts the ages of CLP 
and GMP cells. All the results above demonstrate that EpiAgent not only delineates discrete cell 
types but also captures developmental heterogeneity effectively. 
Supervised cell annotation. Supervised cell annotation leverages reference dataset labels to train 
models for identifying cell types in query data, which is another crucial task in scATAC-seq 
analysis. For fine-tuning, we fed the EpiAgent output [CLS] token embeddings into a multilayer 
perceptron (MLP) classifier to adapt for this task. We compared EpiAgent against five baseline 
methods: Principal Component Analysis and Support Vector Machine (PCA+SVM)42, MLP43, 
EpiAnno19, CellCano20, and SANGO21. Although PCA+SVM and MLP are not specifically 
designed for scATAC-seq data, they are selected due to their superior performance in benchmarks 
for methods based on scRNA-seq data42,43. Each dataset is randomly split, with two-thirds serving 
as the reference dataset for training and the remaining one-third as the query dataset. Annotation 
performance is evaluated by accuracy and macro F1, with macro F1 revealing the ability of 
models for annotating rare cell types. Details on experimental setup, metric calculations, 
fine-tuning of EpiAgent, and baseline methods are provided in Methods. 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

 
As shown in Fig. 2h, EpiAgent achieves the superior performance across datasets, 
outperforming the second-best methods by an average of 11.036% in accuracy (CellCano) and 
21.549% in macro F1 (SANGO). Sankey diagrams (Fig. 2i) and confusion matrices 
(Supplementary Figs. 4-8) also highlight the robust annotation of EpiAgent across diverse cell 
population distributions or dataset sizes, accurately identifying both major and rare cell types. 
Such the stability can be attributed to the unique pretraining strategy for EpiAgent, while the 
performance of baseline methods shows considerable variability across datasets, suggesting their 
limited generalizability. 
Data imputation. The extreme sparsity and low signal-to-noise ratio of scATAC-seq data can 
introduce substantial bias in downstream analyses, therefore data imputation is also a crucial step. 
Leveraging its signal decoder, EpiAgent can reconstruct cell-by-cCRE matrices from cell 
embeddings. We compared EpiAgent with raw data and two imputation methods specifically 
designed for scATAC-seq, scCASE23 and scOpen22, following the same evaluation that contains a 
unified dimensionality reduction and clustering as in scCASE and scOpen. Notably, scCASE and 
scOpen use complete cell-by-cCRE matrices as input, whereas EpiAgent only requires cell 
sentences composed of accessible cCRE indices. Detailed experimental settings, metric 
calculations, EpiAgent fine-tuning, and baseline descriptions are provided in Methods. 
Clustering metrics reveal that EpiAgent achieved stable and efficient data imputation, with 
imputed data showing an average improvement of 11.123% in NMI and 18.605% in ARI over raw 
data. In contrast, baseline methods get inconsistent performance, sometimes underperforming 
compared to direct analysis of raw signals. UMAP visualizations also support the clustering 
results (Supplementary Fig. 9-12). To further validate imputation quality, we averaged signals 
from cells of the same cell type as ground truths and compared them to imputed signals using 
Pearson correlation coefficients. EpiAgent achieves the highest correlation, with median values 
exceeding 0.8 (Fig. 2m). Although EpiAgent does not explicitly aggregate embeddings based on 
cell similarity in latent space, as scCASE and scOpen do, its transformer architecture effectively 
enhances cellular heterogeneity and filters out irrelevant noise when reconstructing signals. 
Moreover, compared to baseline methods, EpiAgent consistently achieves lower MSE values and 
higher Pearson correlation coefficients between imputed and raw data at both the cCRE and cell 
levels, suggesting the ability to effectively reconstruct raw signals from compressed cell 
sentences. 
 
EpiAgent accurately predicts cellular responses to out-of-sample stimulated and unseen 
genetic perturbations 
Single-cell characterization of cellular responses to perturbations illuminates fundamental 
principles of gene regulation and cellular function44, thereby informing pharmacological strategies, 
clinical interventions, and diagnostic advances45,46. Perturbations generally fall into two categories: 
external stimulations, such as electric shocks or drug treatments, and genetic perturbations, such as 
CRISPR-mediated gene editing. Advances in single-cell sequencing technologies have enabled the 
profiling cellular responses to these perturbations at the epigenomic level. However, due to the 
challenges posed by the high dimensionality and sparsity of scATAC-seq data, no existing 
methods have been specifically developed for single-cell perturbation prediction at the epigenomic 
level. Leveraging the transformer-based architecture, EpiAgent introduces an innovative approach 
by modifying cell sentences: it incorporates a perturbation-specific token into the [CLS] token of 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

unperturbed cells to predict their post-perturbation states (Fig. 3a). For a single external 
stimulation, such as an electric shock or a single drug treatment, a learnable [PER] token 
represents the perturbation signal. For genetic perturbations, each gene is modeled as a learnable 
token, integrated through a Graph Neural Network (GNN) with Gene Ontology (GO)47 
relationships as edges, enabling the prediction of unseen genetic perturbations (Fig. 3b). 
 
Fig. 3 | Prediction of cellular responses to out-of-sample stimulated and unseen genetic 
perturbations using EpiAgent. a, Workflow for predicting the post-perturbation state from the 
corresponding unperturbed cell using the fine-tuned EpiAgent model. b, Workflow for obtaining 
perturbation-specific embeddings for genetic perturbations. c-g, Benchmarking performance for 
prediction of cellular responses to out-of-sample stimulated perturbations. c, Coefficients of 
determination (RÂ²) for mean cCRE accessibility between raw signals and predicted signals from 
different methods, evaluated across all cCREs and the top 1,000 DA cCREs. Bar heights denote the 
mean, and error bars denote the 95% confidence intervals. d, Linear regression fit for mean 
accessibility of the top 1,000 DA cCREs between raw signals and predicted signals from different 
methods, with mono-1 cells as query data. e, Prediction accuracy for accessibility change directions 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

under varying numbers of top upgraded/downgraded DA cCREs. f, Wasserstein distance between raw 
signals and predicted signals from different methods for the top 1,000 DA cCREs. g, UMAP 
visualization of cell embeddings from different methods for unperturbed cells, perturbed cells, and 
predicted perturbed cells, with mono-1 cells as query data. h & i, Benchmarking performance for 
prediction of cellular responses to unseen genetic perturbations. h, Pearson correlation coefficients for 
mean cCRE accessibility between raw signals and predicted signals from different methods, evaluated 
for the top 1,000 DA cCREs. Each point represents the results for a specific gene perturbation. i, 
Prediction accuracy for accessibility change directions under varying numbers of top 
upgraded/downgraded DA cCREs. In e & i, the numbers on the axes indicate the sizes of the sets of 
upregulated and downregulated DA cCREs being evaluated. In f & i, the upper, middle, and lower 
edges of the boxes denote the upper quartile, median, and lower quartile, respectively, and error bars 
denote the maximum and minimum values, excluding outliers. 
 
Out-of-sample stimulated perturbation. Lareau et al.48 used dsciATAC-seq to profile chromatin 
accessibility in untreated control and ex vivo cultured, lipopolysaccharide-stimulated bone 
marrow mononuclear cells (BMMCs). We conducted experiments in which perturbed cells of one 
cell type serve as the query dataset, and the remaining cells serve as the reference dataset. The 
process was repeated until all perturbed cells had been used as the query dataset. Notably, only the 
resting cells are in the Human-scATAC-Corpus, preventing any risk of data leakage. EpiAgent was 
fine-tuned on the reference dataset, and scGen49 and scPRAM50 were trained as baseline methods 
for comparison. Due to characteristics of high dimensionality and large cell count, other 
corresponding methods51,52 could not be executed successfully and were therefore excluded from 
the comparison. Details on experimental setup, fine-tuning of EpiAgent, and baseline methods are 
provided in Methods. 
 
As shown in Fig. 3c, EpiAgent demonstrates its superior performance, showing high 
correlation between predicted and real signals of mean accessibility of all cCREs, surpassing 
scGen and scPRAM by an average of 2.504% and 59.240% for all cell types, respectively. For the 
top 1,000 differentially accessible (DA) cCREs, the advantages increase to 17.112% and 99.680%, 
highlighting the ability of EpiAgent to accurately predict accessibility changes specific and 
sensitive to perturbations. For example, in "mono-1" cells (Fig. 3d), average accessibility of DA 
cCREs predicted by EpiAgent closely aligns with the real signal, forming an almost perfect linear 
relationship, while scGen and scPRAM fail to capture this intrinsic pattern. Such a trend is also 
observed across other cell types (Supplementary Fig. 13). EpiAgent also shows remarkable 
accuracy in predicting the direction of accessibility changes for DA cCREs under perturbation. 
When DA cCREs are divided into upregulated and downregulated groups, EpiAgent consistently 
outperforms baselines in predicting the overall accuracy for varying numbers of top DA cCREs. 
For the most perturbation-sensitive cCREs, such as the top 100 upgraded/downgraded DA cCREs, 
EpiAgent achieves an average accuracy even exceeding 90%. 
 
Beyond predicting overall signals, EpiAgent effectively captures heterogeneity of individual 
cells in responses to perturbations. By calculating the Wasserstein distance of top 1,000 DA 
cCREs between perturbed cells and the predicted by each method, we found EpiAgent gets lower 
distance values than those of scGen and scPRAM, indicating closer alignment of cellular 
distributions between the predicted and real signals. Visualization of cell embeddings (Fig. 3g and 
Supplementary Fig. 14) reveals that, in latent space of EpiAgent, predicted post-perturbation cells 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

nearly overlap with the real while maintaining clear separation from pre-perturbation cells. In 
contrast, baseline methods either completely separate or overly merge the three cell populations in 
their latent space.  
Unseen genetic perturbation prediction. Liscovitch-Brauer et al.53 and Pierce et al.54 developed 
CRISPR-sciATAC and Spear-ATAC technologies, respectively, enabling simultaneous capture of 
chromatin accessibility profiles and CRISPR perturbations. These datasets include chromatin 
accessibility changes in GM12878, K562, and MCF7 cells before and after various gene 
knockouts. Following GEARS55, we extracted 25% of perturbation-related cells from each dataset 
as the query dataset and fine-tuned EpiAgent on the remaining cells. GEARS was trained as a 
baseline method for comparison. As shown in Fig. 3h, EpiAgent outperforms GEARS in 
predicting changes of mean cCRE accessibility under different genetic perturbations. In the 
Liscovitch-Brauer2021 dataset, EpiAgent achieves an average Pearson correlation coefficient 
24.454% higher than GEARS, while in the Pierce2021 dataset, GEARS even fails to predict 
perturbation-induced signals effectively (Fig. 3h). Compared to EpiAgent, GEARS lacks both a 
transformer architecture and a pretraining strategy, limiting its ability to accurately capture 
information from regulatory network and predict genetic perturbations at the epigenomic level. 
Such the limitation is also evident in the accuracy of predicting accessibility change directions for 
top upgraded/downgraded DA cCREs, where GEARS performed only slightly better than random 
guessing, while EpiAgent demonstrates significantly higher accuracy (Fig. 3i). 
Collectively, all the aforementioned results highlight the superiority of EpiAgent to 
accurately characterize cellular heterogeneity under both stimulated and genetic perturbations by 
leveraging its unique transformer-based structure, pretraining strategy, and integration of 
perturbation-specific tokens. 
EpiAgent facilitates reference data integration and query data mapping 
As previously demonstrated, EpiAgent can extract cell embeddings that encapsulate cellular 
heterogeneity from a single dataset. However, in practical scenarios such as constructing cell 
atlases, cells are typically derived from multiple datasets, and batch effects, that is external factors 
such as differences in sequencing technologies or depths, will be introduced and result in 
variations in sequencing data for the same cell types across datasets56. For the correction of batch 
effects, EpiAgent incorporates a batch-specific token embedding to generate batch-invariant cell 
embeddings, and once integrated, these corrected cells can serve as reference data (Fig. 4a). When 
newly-sequencing data is introduced as query data, EpiAgent generates cell embeddings that can 
be directly mapped to the reference dataset using mutual nearest neighbor (MNN) relationships, 
enabling downstream tasks such as label transfer (Fig. 4b).  
Here we constructed a reference dataset of the human brain using cells partially derived from 
the Li2023a8, Lee202357, and Li2023b39 datasets, and notably, Li2023a and Lee2023 datasets are 
also part of the Human-scATAC-Corpus. Details on data filtering and preprocessing are provided 
in Methods. We fine-tuned EpiAgent on the reference dataset with the batch labels, and compared 
its performance to the zero-shot EpiAgent model and one of the most widely-used dimensionality 
reduction methods, PCA. As shown in Fig. 4c and 4d, without introducing batch information as 
labels, embeddings from the zero-shot EpiAgent model, similar to those derived from PCA, show 
pronounced batch effects between datasets, particularly between Li2023a and the other two 
datasets. In contrast, after fine-tuning, EpiAgent leverages its batch-specific token embedding and 
self-attention mechanism to successfully mitigate or even eliminate batch-specific differences in 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

cells of the same type across datasets. We benchmarked the fine-tuned EpiAgent model against 
baseline methods on perspectives of clustering and batch correction, using NMI and ARI to assess 
clustering performance, and kBET and iLISI to evaluate batch correction performance. EpiAgent 
still achieves the best overall performance, demonstrating its ability to eliminate batch effects 
while preserving cellular heterogeneity (Fig. 4e, Supplementary Fig. 15 & 16). Among the 
baseline methods, CASTLE, SCALEX, and scBasset also include batch correction modules, 
enabling partial mitigation of batch effects, while SCALE and cisTopic lack the corresponding 
mechanisms, resulting in distinct batch-specific boundaries similar to those observed with PCA. 
We further evaluated the query data mapping capability of EpiAgent using a single-cell 
multi-omics human brain datasets generated by 10X Genomics as query data (Fig. 4f). Query cells 
are mapped onto the reference dataset, with the labels of their 20 nearest neighbors in the 
reference dataset used for label transfer (Fig. 4g). The transferred labels were validated against the 
expression of marker genes for each cell type (Fig. 4h). Across nearly all cell types, the labels 
transferred by EpiAgent show strong concordance with marker gene expression. For major cell 
types, such as astrocytes, EpiAgent distinguishes them with high clarity; for rare cell types, such 
as endothelial cells, which contain very few cells and are difficult to be identified in single-dataset 
clustering, EpiAgent assigns them labels via mapping, surpassing the limitations of clustering 
within individual datasets. In summary, the fine-tuned EpiAgent model enables effective reference 
data integration by minimizing batch effects and accurate query data mapping without requiring 
additional training or batch-specific information, highlighting the potential as a robust tool for 
constructing large-scale, multi-dataset scATAC-seq cell atlases. 
 
Fig. 4 | Reference data integration and query data mapping using EpiAgent. a, Workflow for the 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

integration of reference data using the fine-tuned EpiAgent model. b, Workflow for mapping query 
data onto the integrated reference data using the fine-tuned EpiAgent model, followed by label transfer. 
c-d, UMAP visualization of the reference dataset using cell embeddings derived from the fine-tuned 
EpiAgent model, the zero-shot EpiAgent model, and PCA, labeled by batches (c) and cell types (d), 
respectively. e, Benchmarking performance of EpiAgent compared to baseline methods, evaluated 
using clustering metrics (NMI and ARI) and batch correction metrics (kBET and iLISI). f, 
Visualization of reference data and query data, with query cells colored separately. g, Visualization of 
query data with transferred labels. h, Marker gene expression for potential cell types in the query 
dataset. Cell embeddings for UMAP visualizations in panels f-h were derived from the fine-tuned 
EpiAgent model. 
 
EpiAgent enables in-silico treatment for cancers through key cCRE knockouts 
Alterations in chromatin accessibility play a critical role in the initiation and progression of cancer, 
while identifying epigenetic drivers and quantitatively evaluating their effects on cancer remains a 
significant challenge58,59. Benefiting from the unique modeling for scATAC-seq data as cell 
sentences composed only of accessible cCRE indices, EpiAgent can directly perform the knockout 
of specific cCREs to observe resulting cellular changes. We extended the capability to the in-silico 
treatment for cancers, investigating whether key cCRE knockouts could potentially transform 
cancer cells towards a more normal-like state (Fig. 5a). For validation, we fine-tuned EpiAgent on 
a clear cell renal cell carcinoma (ccRCC) dataset, which reveals epigenetic regulatory processes 
between normal and cancer cells60. In their studies, Terekhanova et al.60 highlighted two 
regulatory regions associated with the ABCC1 and VEGFA genes that are active across multiple 
cancers, as well as a promoter specific to ccRCC corresponding to the EGLN3 gene. By 
visualizing the accessibility of all cCREs upstream of the transcription start sites (TSS) for these 
genes (ABCC1 and VEGFA: 2,000 bps upstream; EGLN3: 5,000 bps upstream), we identified 
their promoters, highlighted in red in Fig. 5b, as targets for knockout. 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

 
Fig. 5 | In-silico treatment for cancers through key cCRE knockouts using EpiAgent. a, Workflow 
for knocking out key cCREs using the fine-tuned EpiAgent model. b, Accessibility of cCREs upstream 
of the TSS for key genes in ccRCC (ABCC1 and VEGFA: 2,000 bp upstream; EGLN3: 5,000 bp 
upstream). Promoters identified as the target cCREs for knockout are highlighted in red. c, 
Visualization of the reference dataset comprising chimeric cells with varying cancerization scores. 
Manifold denote changes in cancerization scores, and arrows denote the direction from low to high 
cancerization levels. d, Directional shifts of query cells in response to knockouts of different promoters 
(arrows) against the background of the reference dataset. "Group" represents the combined knockout of 
the promoters for all three genes. e, Magnitude of cancerization score changes following individual 
promoter knockouts (ABCC1, VEGFA, EGLN3) and the combined knockout, compared to random 
cCRE knockouts. Bars represent mean values, and error bars denote the 95% confidence interval. 
One-sided t-tests are performed with the alternative hypothesis that the mean is less than 0. 
 
To quantitatively evaluate the effects of knockout, we first constructed a synthetic dataset 
comprising chimeric cells with varying degrees of cancerization, serving as a reference. 
Specifically, for each chimeric cell, its cell sentence is generated by sampling and concatenating 
the cCRE indices from cell sentences of normal and cancer cells, and the proportion of cCREs 
from cancer cells is defined as its cancerization score (Fig. 5c). Upon the same procedure, we then 
generated a set of chimeric cells with a cancerization score of 0.5 as query cells, and for each 
query cell, we introduced the specific cCRE index into its cell sentence (if absent) and 
subsequently removed it to simulate the knockout process. Detailed steps of construction are 
provided in the Methods. 
With the reference dataset as background, the results show that while knockout of the 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

ABCC1 promoter resulted in an overall directional shift distinct from those induced by knockouts 
of other promoters individually or in combination (referred to as "Group"), all scenarios 
consistently shift cells from higher to lower cancerization scores (Fig. 5d). To quantify effects for 
all knock outs, we identified the nearest neighbors of each query cell in the reference dataset, both 
pre- and post-knockout, within the EpiAgent latent space, and the difference in the mean 
cancerization scores of these neighbors is the magnitude of cancerization score change that we 
defined. As shown in Fig. 5e, comparison against a control group (referred to as "Random"), in 
which random cCREs were knocked out, shows that knockouts of target promoters obtain 
significantly negative changes in cancerization scores (one-tailed t-test, p-value < 0.0001), while 
random knockouts result in changes centered around zero. Among these knockouts, the promoter 
of the EGLN3 gene, a ccRCC-specific key cCRE, demonstrates a far greater effect on reversing 
cancerization compared to cCREs broadly accessible across various cancers. Simultaneous 
knockout of these promoters results in a more pronounced reversal of cancerization compared to 
individual knockouts. The instance shows the ability of EpiAgent for in-silico treatment in ccRCC, 
and also highlights the potential for broader applications of EpiAgent in other cancers and 
diseases. 
 
EpiAgent-B and EpiAgent-NT directly annotate newly-sequencing datasets without 
additional training 
The zero-shot capabilities of the pretrained EpiAgent model are limited to unsupervised feature 
extraction, relying on clustering and prior biological knowledge for cell type annotation. To enable 
direct annotation without additional training, we developed EpiAgent-B and EpiAgent-NT, 
tailored for cell annotation in brain tissues and non-brain tissues, respectively. Specifically, 
EpiAgent-B and EpiAgent-NT build on the pretrained EpiAgent model by replacing the signal 
decoder with a classifier for supervised learning tasks, trained on the Li2023a8 and Zhang20217 
datasets, respectively, using cell-type labels as supervision (Fig. 6a). To mitigate potential batch 
effects that could overshadow true cell type differences, we coarsened the granularity of the 
reference dataset labels. Detailed procedures for training and prediction of EpiAgent-B and 
EpiAgent-NT are provided in Methods. 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

 
Fig. 6 | direct annotation on newly-sequencing datasets using supervised EpiAgent-B and 
EpiAgent-NT models. a, Overview of reference datasets used for training and the architecture of 
EpiAgent-B and EpiAgent-NT. The Li2023a and Zhang2021 datasets were used to train EpiAgent-B 
and EpiAgent-NT, respectively. Cell embeddings for UMAP visualization are derived from the 
pretrained EpiAgent model. b-d, Cell type annotation on the Li2023b dataset using EpiAgent-B. e-g, 
Cell type annotation on the Kanemaru2023 dataset using EpiAgent-NT. b & e, Visualization of the 
Li2023b (b) and Kanemaru2023 (e) datasets, comparing ground-truth labels (left) with predicted labels 
(right) generated by EpiAgent-B (b) and EpiAgent-NT (e). Cell embeddings for UMAP visualization 
are derived from EpiAgent-B (b) and EpiAgent-NT(e), respectively. c & f, Sankey plot for illustrating 
annotated results on the Li2023b (c) and Kanemaru2023 (f) datasets for each cell type. Ground truth 
labels are shown on the left, and predicted cell types using EpiAgent-B (c) and EpiAgent-NT (f) are 
shown on the right. d & g, Annotation performance of EpiAgent-B (d) and EpiAgent-NT(g) on the 
Li2023b (d) and Kanemaru2023 (g) datasets evaluated by accuracy, micro F1, balanced accuracy, and 
macro F1. 
 
Compared to other methods, adapting EpiAgent for direct annotation poses several distinct 
advantages: the EpiAgent architecture is inherently designed for training on large-scale datasets, 
exceeding 100,000 cells, which is currently infeasible for most scATAC-seq-based methods; 
EpiAgent has been pretrained on the massive, unlabeled Human-scATAC-Corpus, which 
significantly enhances the robustness for annotation across various tissues and sequencing 
technologies; EpiAgent uses a standardized set of cCREs covering the majority of datasets, 
mitigating errors introduced by inconsistent features between datasets and bypassing inaccuracies 
stemming from converting cCRE accessibility into gene activity scores; the unique modeling for 
scATAC-seq data in EpiAgent, which exclusively considers accessible cCREs, allows it to 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

maximize attention on cell-type-specific signals without the need for cCRE filtering. 
 
For evaluation, we tested the performance of EpiAgent-B and EpiAgent-NT on the Li2023b 
and Kanemaru2023 datasets, respectively, demonstrating their superior ability for cell type 
annotation (Fig. 6b-g). The visualization of cell embeddings (Fig. 6b & e) shows that, compared to 
the unsupervised EpiAgent model (Supplementary Fig. 2 & 3), the supervised EpiAgent-B and 
EpiAgent-NT models tends to group cells of the same major type into a unified cluster rather than 
into separate subclusters. Although the change may sacrifice some subpopulation heterogeneity in 
the latent space, it significantly enhances the robustness and accuracy of EpiAgent-B and 
EpiAgent-NT for cell type annotation (Fig. 6c & f).  
In terms of overall annotation performance, EpiAgent-B achieves an accuracy and micro F1 
score exceeding 0.89 and 0.94, respectively, while EpiAgent-NT exceeds 0.95 for both metrics 
(Fig. 6d & g). When focusing on each cell type individually, both models demonstrate balanced 
accuracy and macro F1 scores above 0.8, indicating strong performance for both major and rare 
cell types. All the results highlight the effectiveness of EpiAgent-B and EpiAgent-NT for 
pre-annotating scATAC-seq datasets, suggesting that suggesting their potential to be valuable tools 
for scATAC-seq data pre-analysis. 
 
Discussion 
Here, we introduce EpiAgent, the first foundation model specifically designed for scATAC-seq 
data. EpiAgent overcomes several key limitations of existing methods, including limited 
framework generalizability, underutilization of large-scale data, and inability to capture all 
accessible cCREs. By ranking accessible cCREs in each cell according to their importance, 
EpiAgent constructs cell sentences as input, thereby increasing information density while retaining 
critical regulatory signals. EpiAgent includes 1.4 billion parameters overall, with its core module 
(the EpiAgent transformer) containing approximately 56 million parameters. We pretrained 
EpiAgent on the Human-scATAC-Corpus, containing approximately 5 million cells and 35 billion 
tokens, using two newly designed tasksâthe cell-cCRE alignment task and the signal 
reconstruction taskâthat are well-suited to data lacking explicit contextual relationships, allowing 
EpiAgent to capture both cellular heterogeneity and regulatory networks. 
 
To validate the effectiveness, robustness, and versatility of EpiAgent, we conducted 
comprehensive benchmarking across multiple downstream tasks. In unsupervised feature 
extraction, the fine-tuned EpiAgent can generate cell embeddings that effectively capture cellular 
heterogeneity, 
and 
on 
datasets 
with 
cell 
populations 
resembling 
those 
in 
the 
Human-scATAC-Corpus, EpiAgent can achieve performance on par with or even surpassing 
baseline methods under zero-shot settings. For cell type annotation, EpiAgent outperforms 
baseline methods by enabling stable training on large-scale data and achieving consistent 
performance across diverse datasets. Leveraging the signal decoder, EpiAgent not only can 
reconstruct raw signals from cell embeddings, but also can filter noise and provide stable data 
imputation. 
 
We further demonstrated that EpiAgent can incorporate additional information at the [CLS] 
token embedding to accurately predict cellular responses to single external perturbations. By 
substituting the perturbation-specific token embedding with the output from a GO-based graph 
neural network, EpiAgent can accurately predict cellular responses to unseen genetic perturbations. 
Similarly, by introducing batch-specific information into the [CLS] token embedding, EpiAgent 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

can integrate multiple human brain datasets as reference data, enabling query-to-reference 
mapping for label transfer. Leveraging the cell-sentence framework, EpiAgent can also simulate 
in-silico cCRE knockouts in cancer cells, quantifying the impact of promoters of three 
cancer-related genes (ABCC1, VEGFA, and EGLN3) in ccRCC, thereby showcasing its potential 
utility for in-silico treatment. Additionally, we developed EpiAgent-B and EpiAgent-NT, models 
that can annotate cell types in newly sequenced data without additional training. 
Moving forward, we also describe several directions for improving EpiAgent. First, by 
incorporating DNA sequences, we can unify cCREs from multiple species into a shared 
embedding space, enabling the development of a multi-species foundation model beyond human 
cells. Second, by integrating transcriptomic and other multi-omic data into the cell sentences, we 
can develop a comprehensive multi-omic foundation model capable of dissecting regulatory 
networks from multiple perspectives. Finally, by combining EpiAgent with foundation models 
from other domains, such as natural language processing and computer vision, we would pave the 
way for multimodal intelligent agents for cells, transcending the boundaries of omic data alone. 
 
Methods 
Data collection and preprocessing of Human-scATAC-Corpus 
We manually curated 27 datasets from published literatures6,7,9,39,48,57,61-78, along with 10 additional 
PBMC dataset from the 10X Genomics website (https://www.10xgenomics.com/datasets/). Of 
these, 16 datasets include fragment data, while the remaining datasets only provide cell-by-peak 
matrices. Notably, since the data collected in the Human-scATAC-Corpus is unlabeled, conducting 
peak calling across all datasets could bias the identified cCREs towards cell types or tissues with 
larger cell numbers. Therefore, we did not perform peak calling directly on all datasets but instead 
merged publicly available cCRE sets. The curated cCRE set is derived from the following sources: 
an atlas-level dataset containing various human tissues (excluding adult brain)7, an atlas-level 
dataset from human brain tissues8, and a large-scale human blood and bone marrow dataset48. 
Overlapping cCREs were combined into longer intervals, and those accessible in fewer than 100 
cells were excluded. The curated cCRE set contains 1,355,445 cCREs, and overlap analysis 
compared to the peak or cCRE sets from the published datasets demonstrates a high degree of 
concordance, indicating that our curation encompasses the majority of potential cCREs 
(Supplementary Fig. 17 & 18). 
To filter out low-quality cells in the Human-scATAC-Corpus, we removed cells with fewer 
than 100 accessible cCREs. Both fragment data and cell-by-peak matrices were mapped to the 
predefined cCRE set. The data were then segmented into chunks of 5,000 cells each for 
pretraining purposes. Ultimately, the Human-scATAC-Corpus comprise a total of 5,000,000 cells 
across 31 tissues, with a total of 10 billion tokens (accessible cCREs), providing a comprehensive 
resource for pretraining EpiAgent. Detailed information on each preprocessed dataset is available 
in Supplementary Table 1.  
 
Non-zero ranked value tokenization 
All scATAC-seq data in the Human-scATAC-Corpus are preprocessed into a large-scale 
cell-by-cCRE count matrix     , where  and  denote the number of cells and the 
number of cCREs, respectively. Given that the raw count matrix   is quasi-binary, with the 
majority of elements being 0, 1, or 2, we applied a TF-IDF transformation to  , aiming to 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

measure the importance of each cCRE for a given cell based on its occurrence within both the 
individual cell and the entire Human-scATAC-Corpus. Assuming that  is the element of cCRE 
 in cell  in the matrix  , the TF-IDF transformation can be formulated as: 

 	 log 1  
 
â 
 
 â 

  10	, 
where 
  denotes the transformed element corresponding to  in the newly formed matrix  . 
Notably, the TF-IDF transformation does not alter the non-zero values in the cell-by-cCRE matrix 
to zero, nor does it transform zero values into non-zero values. Since the cell-by-cCRE matrix is 
extremely sparse and high-dimensional, during tokenization, we only consider cCREs with 
non-zero values. The ranks of these cCREs are determined by sorting them in the transformed cell 
vector Â·
  in descending order. Through the tokenization, each quasi-binary vector Â· of an 
individual cell is converted into a cell sentence, that is a sequence of cCRE indices  	
,, ,, ... . 
Since EpiAgent is a transformer-based model, the computational cost during forward and 
backward propagation is proportional to the square of the length of the cell sentence. To balance 
computational cost and the need to include as many tokens as possible per cell, we set the 
maximum tokenized cell sentence length to 8190 (excluding the [CLS] and [SEP] tokens). During 
each forward step, if the size of the cCRE index set exceeds the limit, random sampling without 
replacement is performed until the length constraint is met. 
Model architecture of EpiAgent 
EpiAgent consists of three modules: an embedding module, the EpiAgent transformer, and a 
signal decoder. The embedding module converts the sequence of cCRE indices into a sequence of 
embeddings. The EpiAgent transformer takes these embeddings as input, and then generates 
contextual cCRE embeddings via a series of stacked transformer blocks. The output embedding 
corresponding to the [CLS] token serves as the cell embedding. The signal decoder takes the cell 
embedding as input, and reconstructs the raw signals of cCRE accessibility via a single-layer fully 
connected neural network. 
Embedding module 
Embedding module consists of two main components: the cCRE embedding layer and the rank 
embedding layer. Before feeding the sequence of cCRE indices after tokenization into the model, 
two special tokens, [CLS] and [SEP], are added at the start and end, respectively, transforming the 
sequence into 
 	 CLS , ,, ,, ... , SEP #. The cCRE embedding layer takes the processed 
sequence corresponding to each cell as input, and the rank embedding layer takes the sequence of 
rank indices $ 	 %1,2,3, ... ( as input, which is a sequence of natural numbers with the same 
length as the cCRE index sequence for each cell. Embedding module then sums the outputs from 
the two embedding layers, which can be formulated as: 
) 	 embedding_layer%(  embedding_layer%$( 	 4,, 4,, ... 4,#, 
where embedding_layer%Â·( and embedding_layer%Â·( denote the cCRE embedding and 
rank embedding layers, respectively.  
Comparing the similar processing step to models in the NLP domain, the cCRE embedding 
and rank embedding layers are analogous to the word embedding and positional embedding layers, 
respectively. The key distinction is that the number of cCREs is significantly larger than the 
vocabulary size in NLP models, and the ranks represent the relative importance of each cCRE, 
derived from the values after the TF-IDF transformation, instead of raw positional locations in 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

each cell. In embedding module, the dimensionality of embedding is set to 512. The cCRE 
embedding layer contains 1,355,449 embeddings, corresponding to 1,355,445 cCRE tokens and 4 
special tokens. The rank embedding layer consists of 8,192 embeddings, which reflects the 
maximum token capacity (after adding the [CLS] and [SEP] tokens) of the EpiAgent transformer. 
The embedding module contains approximately 695 million parameters.  
EpiAgent transformer 
As the core module of the transformer-based foundational model EpiAgent, the EpiAgent 
transformer consists of 18 stacked transformer blocks with a bidirectional attention mechanism to 
model global dependencies in high-dimensional input data, enabling the capture of epigenetic 
regulatory networks across different cells. Each transformer block operates on inputs and outputs 
with an embedding dimension of 512 and utilizes 8 attention heads. The input and output of each 
stacked transformer block can be formulated as: 
)
 	 ), 
)
  	 transformer_block ;)
 !< 	 ;4,
 
, 4,
 , ...4,
 
<, 
where )
  is the output of the =-th transformer block, and transformer_block%Â·( is a single 
transformer block. The core function of the transformer is to capture interactions between cCREs 
via the bidirectional attention mechanism, which can be formulated as follows: 
> 	 )
 !?"
 , @ 	 )
 !?#
 , A 	 )
 !?$
 , 
Attention%>, @, A( 	 softmax
"#
%& A, 
where ?"
 , ?#
  and ?$
  are trainable weight matrices used to compute the Query (Q), Key 
(K), and Value (V), respectively, and D denotes the dimension of the Key vector. For enhancing 
the representation capability for transformers, each transformer block leverages a multi-head 
attention mechanism by calculating multiple attention heads in parallel. Each attention head has its 
own set of ?"
 , ?#
  and ?$
 , following the same formulation as single-head attention. The 
outputs from all attention heads are concatenated and then linearly transformed using a learnable 
matrix ?'
 , obtaining the output embeddings. The output of the final transformer block is 
)
( 	 ;4,
(
, 4,
(, ... 4,
(
<, where 4,
(
 serves as the cell embedding of cell . The 
EpiAgent transformer contains approximately 57 million parameters and is implemented using the 
Flash Attention v2 framework to ensure efficient training and inference. Detailed parameters of 
the EpiAgent transformer are available in Supplementary Table 2. 
Signal decoder 
Signal decoder employs a single-layer, fully connected neural network to transform cell 
embeddings into the accessibility signals of all cCREs for each cell. The process can be 
formulated as: 
EÂ· 	 F  4,()
(
 G, 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

where F and G are learnable parameters of the single-layer neural network, and EÂ· denotes 
the predicted accessibility signal for cell , based on its cell embedding. The signal decoder 
contains approximately 695 million parameters. 
Pretraining tasks used for EpiAgent 
To simultaneously capture gene regulatory networks and generate cell embedding rich in cellular 
heterogeneity, EpiAgent primarily utilizes two newly-designed tasks for pretraining: the 
cell-cCRE alignment task and the signal reconstruction task.  
 
In the cell-cCRE alignment task, the aim is to train EpiAgent to identify potentially 
accessible cCREs that align with the regulatory networks compressed into the cell embedding. For 
cell , we first obtain its cell embedding 4,
(
 from EpiAgent. Assuming the length of the 
tokenized cell sentence  	 ,, ,, ... # for cell   is H , we perform non-replacement 
sampling from cCREs that are inaccessible in cell  to construct a cCRE index set I 	
J,, J,,... , with a size of minK *+,-H,  L H#, where K *+,- is a pre-defined 
hyperparameter. We then input both  and I into the cCRE embedding layer, obtaining the 
input cCRE embeddings corresponding to the indices in these sets, denoted as )M  	 4Ì ,, 4Ì ,, ...  
and )O  	 4Ì ,, 4Ì ,,... , respectively. Note that these embeddings are pre-transformer embeddings 
and are not influenced by the attention mechanism from other accessible or inaccessible cCREs 
within cell , and thus only reflect information about the cCREs themselves. We then concatenate 
the cCRE embeddings from )M  and )O  with the cell embedding 4,
(
, and merge these sets to 
form a new set )Q 	 Rconcat;4,
(
,4Ì ,< , ... , concat;4,
(
, 4Ì ,< , ... S. Each vector in this 
new set is then passed through a binary classifier to determine whether the cCREs in )M  and )O  
are accessible in cell , i.e., whether cell  aligns with the cCREs in )M  and )O . The task not 
only trains the self-attention mechanism but also engages more parameters from the embedding 
module, promoting faster convergence. The cell-cCRE alignment loss is computed using the 
"BCEWithLogitsLoss()" function in PyTorch, with the parameter "pos_weight" set to K *+,-. 
EpiAgent is pretrained for 12 epochs. During the first 4 epochs, we set K *+,- to 1; 
during the middle 4 epochs, we set K *+,- to 2; and for the final 4 epochs, we set K *+,- 
to 5. As the pretraining progresses, more cCREs are aligned with each cell. 
In the signal reconstruction task, the aim is to enable the model to attend to all cCREs and 
recover the raw accessibility signals from the cell sentence. We first use the tokenized cell 
sentence  	 ,, ,, ... for cell  to generate a binary vector TÂ·, representing whether each 
cCRE in cell  is accessible. The predicted signal is the output EÂ· from the signal decoder, and 
TÂ·  serves as the ground truth. The signal reconstruction loss is computed using 
"BCEWithLogitsLoss()" function in PyTorch, with the parameter "pos_weight" set to 100. The 
use of binary classification instead of regression for reconstruction task serves two purposes: first, 
it accelerates model convergence, and second, it conserves storage resources, as the 
Human-scATAC-Corpus only stores the cCRE indices for each cell, making classification tasks 
more storage-efficient. 
Additionally, we observed that using only the two aforementioned tasks at the start of 
training could cause the pretraining to collapse. A potential reason is that these tasks are overly 
challenging during the warm-up phase of EpiAgent. To mitigate this, we additionally incorporated 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

a replaced language modeling task during the first two epochs. Specifically, after tokenization, 50% 
of the cCREs (i.e., tokens) in each cell are randomly replaced by inaccessible cCREs, and the 
model then predicts whether each cCRE is accessible in the cell. 
Although the EpiAgent transformer adopts an encoder architecture, it is not suitable for 
contextual pretraining tasks such as masked language modeling, primarily for three reasons. First, 
even after applying TF-IDF transformations to convert the quasi-binary cell-by-cCRE matrix into 
that with continuously-valued elements, many cCREs still remain inaccessible in each cell. In this 
context, whether a cCRE is accessible is more informative than subtle quantitative differences in 
its importance score. Second, the cCRE vocabulary is much larger than typical natural language 
vocabularies, making large-scale multi-class classification slow to converge and prone to collapse. 
Third, we aim for EpiAgent to not only leverage attention mechanisms to learn co-open patterns of 
cCREs, i.e., regulatory networks, but also to extract cell embeddings that capture cellular 
heterogeneity. Further details on the pretraining parameters can be found in Supplementary Table 
2. 
 
Downstream analysis 
Unsupervised feature extraction 
In a downstream dataset, EpiAgent is fine-tuned using the same tasks as in pretraining, that is the 
cell-cCRE alignment task and the signal reconstruction task. The only difference in fine-tuning is 
the parameter K *+,- fixed to 1 for the cell-cCRE alignment task. 
EpiAgent was compared against five baseline methods: cisTopic14, SCALE15, scBasset17, 
SCALEX16, and CASTLE18. All five baseline methods are well-designed and capable of 
processing large-scale datasets. We implemented each method according to their publications and 
GitHub documentation, ensuring that all parameters are consistent with the implementation in the 
publications or the default settings. For evaluation, we performed Leiden clustering on the cell 
embeddings obtained from each method, using a binary search approach to ensure that the number 
of clusters matches the actual number of cell types. Clustering performance is assessed using NMI 
and ARI scores. The detailed formulas for computing these metrics are available in Supplementary 
Note 2. 
 
Supervised cell annotation 
In the supervised cell annotation task, EpiAgent is fine-tuned by feeding the output cell 
embeddings into a classifier to perform multi-class classification. The classifier is a single-layer, 
fully connected neural network, and the loss function for fine-tuning is cross-entropy loss. 
EpiAgent was compared against five baseline methods: PCA+SVM42, MLP43, EpiAnno19, 
CellCano20, and SANGO21. EpiAnno could not be executed on large-scale datasets using the 
parameters outlined in their publication. The limitation arises because EpiAnno does not account 
for batch effects and requires loading the entire dataset into the probabilistic graph during training. 
CellCano also encounters memory issues with large datasets. To address these constraints, we 
downsample cells when running both methods on large-scale datasets, keeping all other 
parameters unchanged. Compared to feature downsampling, cell downsampling leads to better 
performance for both EpiAnno and CellCano (Supplementary Fig. 19). Since PCA+SVM and 
MLP are methods specifically developed for scRNA-seq data, we convert the scATAC-seq data 
into gene activity matrices as inputs, aligning with the input used for Cellcano. Other parameters 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

are set to be consistent with the implementations in their publications or the default settings. For 
each dataset, two-thirds of the cells are randomly assigned to the reference dataset, while the 
remaining cells serve as the query dataset. All methods are trained on the reference dataset and 
evaluated on the query dataset. We use accuracy and macro F1 for evaluation metrics, with the 
detailed formulas provided in Supplementary Note 2. 
 
Data imputation 
For the data imputation task, the fine-tuning strategy of EpiAgent is also consistent with the tasks 
used during pretraining, that is the cell-cCRE alignment task and the signal reconstruction task. 
The differences in fine-tuning are that, for the cell-cCRE alignment task, K *+,- is set to 1, 
and for the signal reconstruction task, mean squared error (MSE) loss is used for regressing the 
real signal. 
EpiAgent was compared against two baseline methods: scCASE23 and scOpen22. First, we 
perform data imputation with each method and then apply PCA to the imputed data to obtain cell 
embeddings. Next, we conduct Leiden clustering on these embeddings and use a binary search 
procedure to ensure that the number of resulting clusters matches the true number of cell types. 
Clustering performance is assessed using the NMI and ARI scores, where better clustering results 
indicate superior performance on data imputation. The detailed formulas for computing these 
metrics are available in Supplementary Note 2. To make a fair comparison, we standardize the size 
of the cell-by-cCRE matrices used for data imputation across all methods. Specifically, we use a 
unified data preprocessing pipeline, retaining only cCREs accessible in at least 3% of cells. When 
processing datasets with more than 50,000 cells, scCASE triggers a "Segmentation fault (core 
dumped)" error, and scOpen encounters memory issues. In these cases, we randomly downsample 
to 50,000 cells and benchmark all methods on this reduced set. All other parameters are set in 
accordance with the implementations described in their publications or the default settings. 
Out-of-sample stimulated perturbation prediction 
In the task of out-of-sample stimulated perturbation prediction, the fine-tuning process for 
EpiAgent is as follows. First, we input all cells from the reference dataset into the pretrained 
EpiAgent model to obtain their cell embeddings, and employ Optimal Transport (OT) to match 
each perturbed cell with an unperturbed cell for each cell type. The detailed procedure for OT is 
available in Supplementary Note 3. Next, we construct a new reference dataset by duplicating data 
of unperturbed cells. For cells from the original dataset, we use the same training strategy as in 
data imputation (cell-cCRE alignment and signal reconstruction tasks) to allow EpiAgent to learn 
accessibility patterns of all cCREs. For the duplicated unperturbed cells, EpiAgent is trained to 
predict the post-perturbation states. Specifically, before feeding the input into the EpiAgent 
transformer, we introduce a learnable perturbation- specific token ([PER]) embedding in addition 
to the [CLS] token embedding. After obtaining cell embeddings through the EpiAgent transformer, 
the model performs cell-cCRE alignment and signal reconstruction tasks using the matched 
post-perturbation data as ground truth. For reconstructing original signals, the loss used for these 
two tasks is same as that in data imputation. To prevent the model from conflating unperturbed 
and perturbed data, we introduce a binary classification task during fine-tuning: one class consists 
of the original unperturbed cells, while the other class includes both the perturbed cells and the 
duplicated unperturbed cells. Under the training strategy, EpiAgent could leverage the 
perturbation-specific token and the attention mechanism to capture perturbation-related 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

information. For unperturbed cells in the query dataset, EpiAgent can use their tokenized cell 
sentences (the sequences of cCRE indices) as input, along with the perturbation-specific token, to 
generate the predicted accessibility profiles of the corresponding perturbed cells. 
We compare the performance of EpiAgent with two baseline methods: scGen49 and 
scPRAM50. We also considered including CellOT79 and scPreGAN52 as baseline methods. 
However, CellOT lacks GPU acceleration and failed to converge within a week on the dataset that 
we use for evaluation, and scPreGAN encountered a GPU memory issue due to its requirement to 
load the entire dataset into GPU memory at once. Given that scGen and scPRAM are designed for 
scRNA-seq data, which are not well-suited for processing the high-dimensional scATAC-seq data 
in its entirety, we standardize the dataset preprocessing, retaining only the top 50,000 most 
accessible cCREs as input for all methods. For evaluation, data from one cell type is selected as 
the query dataset, while data from other cell types are used as the reference dataset for training, 
repeating until all cell types are used as query datasets. We adopted three main evaluation criteria 
for benchmarking methods. First, to assess the prediction of average post-perturbation 
accessibility patterns, we computed the mean accessibility signals for both the real and predicted 
perturbed cells across all cCREs and the top 1,000 cCREs. Specifically, we fit a linear regression 
model to these mean values and used the resulting RÂ² as a performance metric. Second, to evaluate 
predictions of directional changes in accessibility, we identified an equal number of top up-graded 
and top down-graded DA cCREs from the query dataset, and then measured the accuracy of each 
method in capturing the correct direction of these accessibility changes. Third, to evaluate the 
prediction of cellular heterogeneity for perturbed cells, we used the Wasserstein distance between 
the predicted and real perturbed cells over the 1,000 DA cCREs, as a metric. Wasserstein distance 
is calculated by Euclidean distance based on cell-to-cell matching by OT, with the lower value 
indicating the better performance. The DA cCREs were determined with the "tl.rank_features" 
function in the epiScanpy12 pipeline, based on comparisons of unperturbed and perturbed cells in 
the query dataset. 
 
Unseen genetic perturbation prediction 
For the unseen genetic perturbation prediction task, the fine-tuning process of EpiAgent proceeds 
as follows. Given a genetic perturbation set U 	 V, V, ... , where each element in U represents 
a perturbation corresponding to the knockout of a specific gene. We input each cell from the 
reference dataset into the pretrained EpiAgent model to obtain their cell embeddings, and for each 
gene perturbation, we perform OT to match the perturbed cells with their unperturbed counterparts 
based on the cell embeddings. Our fine-tuning aim is to enable EpiAgent to predict the chromatin 
accessibility landscape of a cell under a given gene perturbation, conditioned on the accessibility 
profile of its unperturbed state and a perturbation-specific token embedding. To achieve this, we 
introduce an additional embedding layer of genetic perturbation and a GNN into EpiAgent. The 
embedding layer contains a set of learnable embeddings W 	 X, X, ... , where each element in 
W is a 512-dimensional vector corresponding to a specific perturbation (gene) in U. These 
embeddings are then processed by the GNN, which incorporates pathway information from GO47 
to establish gene-gene and thus perturbation-perturbation relationships.  
 
During fine-tuning, EpiAgent adds the perturbation-specific embedding on the input [CLS] 
token embedding of the unperturbed cell, and predicts the signals of the matched perturbed cell 
using the same loss as in the data imputation. Unperturbed and perturbed cells also undergo the 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

cell-cCRE alignment and signal reconstruction tasks independently, without incorporating the 
perturbation-related embedding. By integrating these new embedding layers and the GNN, the 
fine-tuned EpiAgent model can generate perturbation-related token embeddings for previously 
unseen genetic perturbations and predict their chromatin accessibility effects when presented with 
chromatin accessibility profile of an unperturbed cell. 
 
We select GEARS55 as the baseline method for comparison. Since GEARS is designed for 
scRNA-seq data and cannot process the high dimensionality of full scATAC-seq data, we 
preprocessed the test datasets to retain only the top 50,000 most accessible cCREs. We adopted 
two main evaluation criteria for benchmarking methods. First, to assess the prediction of average 
post-perturbation accessibility patterns, we compute Pearson correlation coefficients between the 
average accessibility signals of the top 1,000 DA cCREs in the real and predicted perturbed cells. 
Second, we evaluated predictions of directional changes in accessibility, with the same procedure 
in out-of-sample stimulated perturbation prediction. The DA cCREs were determined with the 
"tl.rank_features" function in the epiScanpy pipeline, based on comparisons of unperturbed and 
perturbed cells in the query dataset. 
 
Reference data integration and query data mapping 
In the reference data integration task, the fine-tuning process for EpiAgent is as follows. We input 
all the data into the pretrained EpiAgent model to obtain cell embeddings, and then use OT to 
match cells across different datasets (also served as batches). The detailed procedure for OT is 
available in Supplementary Note 3. Since there may be differences in cell populations between 
datasets, we apply a filtering process to the matched cell pairs. For each dataset pair, we calculate 
the distance between each matched pair and then train a Gaussian Mixture Model (GMM) with 
two components to classify the pairs. We consider the pairs belonging to the Gaussian distribution 
with the smaller mean as high-quality matches and retain them, while discarding the rest. For each 
batch of data, before inputting them into the EpiAgent transformer, we add a batch-specific token 
(e.g., [Batch 1], [Batch 2], [Batch 3], etc.) embedding on the [CLS] token embedding. The 
batch-specific tokens are designed to capture non-biological variations, such as technical 
differences. During fine-tuning, EpiAgent performs both the cell-cCRE alignment and signal 
reconstruction tasks, while the ground truths for the two tasks are derived not only from the cells 
themselves but also from their matched counterparts in other batches. Cells that do not have a 
match in other batches only use their own data for the ground truth. When generating cell 
embeddings, EpiAgent can optionally include or exclude the batch-specific token to decide 
whether or not the resulting embeddings eliminate batch-specific differences. We use NMI and 
ARI as clustering metrics, and kBET80 and iLISI as batch correction metrics. Clustering is 
performed using Leiden clustering, with the number of clusters set to match the actual number of 
cell types. The calculation of NMI and ARI is detailed in Supplementary Note 2, and kBET and 
iLISI were computed directly using the original code from scIB81. 
In the query data mapping task, we assume the reference data has already been constructed 
by the fine-tuned EpiAgent model. For the query data, we input it directly into the fine-tuned 
EpiAgent model without the batch-specific token to obtain cell embeddings for the query data. 
Using MNN, EpiAgent identifies the 20 nearest neighbors in the reference dataset for each query 
cell in the cell embedding space, thus mapping the query data to the reference data. Then we can 
transfer the labels from reference data to query data, by assigning the label of the majority among 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

the 20 nearest reference cells to each query cell. 
 
In-silico treatment 
For in-silico treatment, the process for EpiAgent is as follows. We first fine-tune EpiAgent on the 
cancer dataset using the same tasks as in unsupervised feature extraction, obtaining embeddings 
for both cancer cells and normal cells. Using the cell embeddings, we then use Leiden clustering 
on these cells to remove outliers or misannotated cells, and perform OT to match each cancer cell 
with a corresponding normal cell. For each matched pair, we create a synthetic cell with its cell 
sentence derived from randomly sampling cCRE indices from both cancer and normal cells, and 
the proportion of cCREs from the cancer cell defines the cancerization score. We set cancerization 
scores uniformly distributed between 0 and 1 to construct a reference dataset, and these synthetic 
cells are input into the fine-tuned EpiAgent model to generate embeddings for quantitative 
analysis.  
 
To simulate a cCRE knockout for a given target cCRE, we construct a query dataset of 
synthetic cells with a cancerization score fixed at 0.5. If a target cCRE does not appear in the 
sentence of a synthetic cell, we add it. We then remove the target cCRE from the cell sentence to 
simulate its knockout. We input the cells before and after knockout into the fine-tuned EpiAgent 
model to obtain their embeddings. We then identify the 20 nearest neighbors of each query cell 
from the reference dataset before and after knockout, and measure how average cancerization 
scores of neighbors change. The change quantifies the magnitude of the cancerization score 
change resulting from the cCRE knockout. 
 
EpiAgent-B and EpiAgent-NT model 
Building on the pretrained EpiAgent model, we trained two additional modelsâEpiAgent-B and 
EpiAgent-NTâdesigned to directly annotate query data without the need for collecting reference 
data for training. Specifically, EpiAgent-B is used to annotate cells from brain tissues, whereas 
EpiAgent-NT targets cells from normal tissues excluding the brain. The training data are sourced 
from two well-annotated datasets in the Human-scATAC-Corpus: the Li2023a8 dataset, a cell atlas 
of brain tissues, and the Zhang20217 dataset, a cell atlas of human normal tissues excluding the 
brain.  
Before training, we aggregated cell type labels from these two datasets, and the mapping 
relationships between cell types before and after aggregation are detailed in Supplementary Table 
3 and 4. The preprocessing step is necessary because overly fine-grained cell annotations could 
lead to batch effects overshadowing true cell type differences between the query and training data, 
potentially causing misannotations in the query data. The settings for training and parameters for 
classifier are consistent with those used in the supervised cell annotation task. In addition to the 
accuracy and macro F1 metrics used in the supervised cell annotation task, we also introduced 
micro F1 and balanced accuracy to further evaluate overall annotation performance as well as 
performance across each cell type. Detailed formulas for the metrics are provided in 
Supplementary Note 2. 
 
Data availability 
The Human-scATAC-Corpus includes 27 published datasets6,7,9,39,48,57,61-78 and 10 publicly 
available 
PBMC 
datasets 
from 
the 
10x 
Genomics 
website 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

(https://www.10xgenomics.com/datasets/). All these datasets are publicly accessible, and detailed 
statistics and data availability are provided in Supplementary Table 1. Additional 
datasets37-40,48,53,54,60 not included in the Human-scATAC-Corpus, but used for evaluating 
EpiAgent in downstream analyses, are also publicly available, with detailed statistics and data 
availability provided in Supplementary Table 5. 
 
Code availability 
The EpiAgent is freely available on Github (https://github.com/xy-chen16/EpiAgent). 
 
Acknowledgements 
This work was supported by the National Key Research and Development Program of China 
(grant nos. 2023YFF1204802 and 2021YFF1200902) and the National Natural Science 
Foundation of China (grant nos. 62273194). 
 
Author contributions 
R.J. conceived the study and supervised the project. X.C. collected and processed all data in 
Human-scATAC-Corpus and downstream analyses, and designed, implemented and validated 
EpiAgent. K.L. assisted in analyzing the results for data imputation, prediction of unseen genetic 
perturbations, and in-silico treatment. X.C. contributed to analyzing the results for unsupervised 
feature extraction and reference data integration. Z.W. helped with analyzing the results for 
supervised cell type annotation and validation of EpiAgent-B and EpiAgent-NT. Q.J. aided in the 
analysis prediction of out-of-sample stimulated perturbations. J.L. contributed to designing the 
pretraining tasks. Z.L. and Z.G. helped with implementing EpiAgent. X.C., K.L. and R.J. wrote 
the manuscript, with input from all the authors. 
 
Competing interests 
The authors declare no competing interests. 
 
References 
1 
Klemm, S. L., Shipony, Z. & Greenleaf, W. J. Chromatin accessibility and the regulatory 
epigenome. Nat Rev Genet 20, 207-220 (2019). https://doi.org/10.1038/s41576-018-0089-8 
2 
Minnoye, L. et al. Chromatin accessibility profiling methods. Nat Rev Methods Primers 1 
(2021). https://doi.org/10.1038/s43586-020-00008-9 
3 
Buenrostro, J. D. et al. Single-cell chromatin accessibility reveals principles of regulatory 
variation. Nature 523, 486-490 (2015). https://doi.org/10.1038/nature14590 
4 
Pijuan-Sala, B. et al. Single-cell chromatin accessibility maps reveal regulatory programs 
driving 
early 
mouse 
organogenesis. 
Nat 
Cell 
Biol 
22, 
487-497 
(2020). 
https://doi.org/10.1038/s41556-020-0489-9 
5 
Chiou, J. et al. Single-cell chromatin accessibility identifies pancreatic islet cell type- and 
state-specific regulatory programs of diabetes risk. Nat Genet 53, 455-466 (2021). 
https://doi.org/10.1038/s41588-021-00823-0 
6 
Domcke, S. et al. A human cell atlas of fetal chromatin accessibility. Science 370, 809-+ 
(2020). https://doi.org/10.1126/science.aba7612 
7 
Zhang, K. et al. A single-cell atlas of chromatin accessibility in the human genome. Cell 184, 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

5985-6001 e5919 (2021). https://doi.org/10.1016/j.cell.2021.10.024 
8 
Li, Y. E. et al. A comparative atlas of single-cell chromatin accessibility in the human brain. 
Science 382, eadf7044 (2023). https://doi.org/10.1126/science.adf7044 
9 
Mannens, C. C. et al. Dynamics of chromatin accessibility during human first-trimester 
neurodevelopment. bioRxiv, 2023.2008. 2018.553878 (2023).  
10 
Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state 
analysis 
with 
Signac. 
Nat 
Methods 
18, 
1333-1341 
(2021). 
https://doi.org/10.1038/s41592-021-01282-5 
11 
Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin 
accessibility 
analysis. 
Nat 
Genet 
53, 
403-411 
(2021). 
https://doi.org/10.1038/s41588-021-00790-6 
12 
Danese, A. et al. EpiScanpy: integrated single-cell epigenomic analysis. Nat Commun 12, 
5228 (2021). https://doi.org/10.1038/s41467-021-25131-3 
13 
Fang, R. et al. Comprehensive analysis of single cell ATAC-seq data with SnapATAC. Nat 
Commun 12, 1337 (2021). https://doi.org/10.1038/s41467-021-21583-9 
14 
Bravo Gonzalez-Blas, C. et al. cisTopic: cis-regulatory topic modeling on single-cell 
ATAC-seq data. Nat Methods 16, 397-400 (2019). https://doi.org/10.1038/s41592-019-0367-1 
15 
Xiong, L. et al. SCALE method for single-cell ATAC-seq analysis via latent feature extraction. 
Nat Commun 10, 4576 (2019). https://doi.org/10.1038/s41467-019-12630-7 
16 
Xiong, L. et al. Online single-cell data integration through projecting heterogeneous datasets 
into 
a 
common 
cell-embedding 
space. 
Nat 
Commun 
13, 
6118 
(2022). 
https://doi.org/10.1038/s41467-022-33758-z 
17 
Yuan, H. & Kelley, D. R. scBasset: sequence-based modeling of single-cell ATAC-seq using 
convolutional 
neural 
networks. 
Nat 
Methods 
19, 
1088-1096 
(2022). 
https://doi.org/10.1038/s41592-022-01562-8 
18 
Cui, X. et al. Discrete latent embedding of single-cell chromatin accessibility sequencing data 
for 
uncovering 
cell 
heterogeneity. 
Nat 
Comput 
Sci 
4, 
346-359 
(2024). 
https://doi.org/10.1038/s43588-024-00625-4 
19 
Chen, X. et al. Cell type annotation of single-cell chromatin accessibility data via supervised 
Bayesian 
embedding. 
Nature 
Machine 
Intelligence 
4, 
116-126 
(2022). 
https://doi.org/10.1038/s42256-021-00432-w 
20 
Ma, W., Lu, J. & Wu, H. Cellcano: supervised cell type identification for single cell ATAC-seq 
data. Nat Commun 14, 1864 (2023). https://doi.org/10.1038/s41467-023-37439-3 
21 
Zeng, Y. et al. Deciphering cell types by integrating scATAC-seq data with genome sequences. 
Nat Comput Sci 4, 285-298 (2024). https://doi.org/10.1038/s43588-024-00622-7 
22 
Li, Z. et al. Chromatin-accessibility estimation from single-cell ATAC-seq data with scOpen. 
Nat Commun 12, 6386 (2021). https://doi.org/10.1038/s41467-021-26530-2 
23 
Tang, S. et al. scCASE: accurate and interpretable enhancement for single-cell chromatin 
accessibility 
sequencing 
data. 
Nat 
Commun 
15, 
1629 
(2024). 
https://doi.org/10.1038/s41467-024-46045-w 
24 
Zhao, Z., Li, Z. & Yu, N. Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, 
et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective 
Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53. Eur Urol 85, e83-e84 
(2024). https://doi.org/10.1016/j.eururo.2023.12.006 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

25 
Awais, M. et al. Foundational models defining a new era in vision: A survey and outlook. 
arXiv preprint arXiv:2307.13721 (2023).  
26 
Fu, C. et al. MME-Survey: A Comprehensive Survey on Evaluation of Multimodal LLMs. 
arXiv preprint arXiv:2411.15296 (2024).  
27 
Han, X. et al. Pre-trained models: Past, present and future. AI Open 2, 225-250 (2021). 
https://doi.org/10.1016/j.aiopen.2021.08.002 
28 
Yang, F. et al. scBERT as a large-scale pretrained deep language model for cell type 
annotation of single-cell RNA-seq data. Nature Machine Intelligence 4, 852-866 (2022). 
https://doi.org/10.1038/s42256-022-00534-z 
29 
Theodoris, C. V. et al. Transfer learning enables predictions in network biology. Nature 618, 
616-624 (2023). https://doi.org/10.1038/s41586-023-06139-9 
30 
Cui, H. et al. scGPT: toward building a foundation model for single-cell multi-omics using 
generative 
AI. 
Nat 
Methods 
21, 
1470-1480 
(2024). 
https://doi.org/10.1038/s41592-024-02201-0 
31 
Hao, M. et al. Large-scale foundation model on single-cell transcriptomics. Nat Methods 21, 
1481-1491 (2024). https://doi.org/10.1038/s41592-024-02305-7 
32 
Yang, X. et al. GeneCompass: deciphering universal gene regulatory mechanisms with a 
knowledge-informed cross-species foundation model. Cell Res 34, 830-845 (2024). 
https://doi.org/10.1038/s41422-024-01034-y 
33 
Szalata, A. et al. Transformers in single-cell omics: a review and new perspectives. Nat 
Methods 21, 1430-1443 (2024). https://doi.org/10.1038/s41592-024-02353-z 
34 
Lotfollahi, M. Toward learning a foundational representation of cells and genes. Nat Methods 
21, 1416-1417 (2024). https://doi.org/10.1038/s41592-024-02367-7 
35 
Dao, T. FlashAttention-2: Faster Attention with Better Parallelism and Work Partitioning 
arXiv. arXiv (2023).  
36 
Heumos, L. et al. Best practices for single-cell analysis across modalities. Nat Rev Genet 24, 
550-572 (2023). https://doi.org/10.1038/s41576-023-00586-w 
37 
Buenrostro, J. D. et al. Integrated Single-Cell Analysis Maps the Continuous Regulatory 
Landscape of Human Hematopoietic Differentiation. Cell 173, 1535-1548 e1516 (2018). 
https://doi.org/10.1016/j.cell.2018.03.074 
38 
Kanemaru, K. et al. Spatially resolved multiomics of human cardiac niches. Nature 619, 
801-810 (2023). https://doi.org/10.1038/s41586-023-06311-1 
39 
Li, J. et al. Divergent single cell transcriptome and epigenome alterations in ALS and FTD 
patients 
with 
C9orf72 
mutation. 
Nat 
Commun 
14, 
5714 
(2023). 
https://doi.org/10.1038/s41467-023-41033-y 
40 
Ameen, M. et al. Integrative single-cell analysis of cardiogenesis identifies developmental 
trajectories and non-coding mutations in congenital heart disease. Cell 185, 4937-4953 e4923 
(2022). https://doi.org/10.1016/j.cell.2022.11.028 
41 
Xiao, Y. et al. Tracking single-cell evolution using clock-like chromatin accessibility loci. Nat 
Biotechnol, 1-15 (2024). https://doi.org/10.1038/s41587-024-02241-z 
42 
Abdelaal, T. et al. A comparison of automatic cell identification methods for single-cell RNA 
sequencing data. Genome Biol 20, 194 (2019). https://doi.org/10.1186/s13059-019-1795-z 
43 
Ma, W., Su, K. & Wu, H. Evaluation of some aspects in supervised cell type identification for 
single-cell RNA-seq: classifier, feature selection, and reference construction. Genome Biol 22, 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

264 (2021). https://doi.org/10.1186/s13059-021-02480-2 
44 
Peidli, S. et al. scPerturb: harmonized single-cell perturbation data. Nat Methods 21, 531-540 
(2024). https://doi.org/10.1038/s41592-023-02144-y 
45 
Burkhardt, D. B. et al. Quantifying the effect of experimental perturbations at single-cell 
resolution. Nat Biotechnol 39, 619-629 (2021). https://doi.org/10.1038/s41587-020-00803-5 
46 
Wills, Q. F. et al. Single-cell gene expression analysis reveals genetic associations masked in 
whole-tissue 
experiments. 
Nat 
Biotechnol 
31, 
748-752 
(2013). 
https://doi.org/10.1038/nbt.2642 
47 
Harris, M. A. et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids 
Res 32, D258-261 (2004). https://doi.org/10.1093/nar/gkh036 
48 
Lareau, C. A. et al. Droplet-based combinatorial indexing for massive-scale single-cell 
chromatin 
accessibility. 
Nat 
Biotechnol 
37, 
916-924 
(2019). 
https://doi.org/10.1038/s41587-019-0147-6 
49 
Lotfollahi, M., Wolf, F. A. & Theis, F. J. scGen predicts single-cell perturbation responses. Nat 
Methods 16, 715-721 (2019). https://doi.org/10.1038/s41592-019-0494-8 
50 
Jiang, Q., Chen, S., Chen, X. & Jiang, R. scPRAM accurately predicts single-cell gene 
expression perturbation response based on attention mechanism. Bioinformatics 40 (2024). 
https://doi.org/10.1093/bioinformatics/btae265 
51 
Bunne, C. et al. Learning single-cell perturbation responses using neural optimal transport. 
Nat Methods 20, 1759-1768 (2023). https://doi.org/10.1038/s41592-023-01969-x 
52 
Wei, X., Dong, J. & Wang, F. scPreGAN, a deep generative model for predicting the response 
of single-cell expression to perturbation. Bioinformatics 38, 3377-3384 (2022). 
https://doi.org/10.1093/bioinformatics/btac357 
53 
Liscovitch-Brauer, N. et al. Profiling the genetic determinants of chromatin accessibility with 
scalable 
single-cell 
CRISPR 
screens. 
Nat 
Biotechnol 
39, 
1270-1277 
(2021). 
https://doi.org/10.1038/s41587-021-00902-x 
54 
Pierce, S. E., Granja, J. M. & Greenleaf, W. J. High-throughput single-cell chromatin 
accessibility CRISPR screens enable unbiased identification of regulatory networks in cancer. 
Nat Commun 12, 2969 (2021). https://doi.org/10.1038/s41467-021-23213-w 
55 
Roohani, Y., Huang, K. & Leskovec, J. Predicting transcriptional outcomes of novel multigene 
perturbations 
with 
GEARS. 
Nat 
Biotechnol 
42, 
927-935 
(2024). 
https://doi.org/10.1038/s41587-023-01905-6 
56 
Argelaguet, R., Cuomo, A. S. E., Stegle, O. & Marioni, J. C. Computational principles and 
challenges in single-cell data integration. Nat Biotechnol 39, 1202-1215 (2021). 
https://doi.org/10.1038/s41587-021-00895-7 
57 
Lee, A. J. et al. Characterization of altered molecular mechanisms in Parkinson's disease 
through cell type-resolved multiomics analyses. Sci Adv 9, eabo2467 (2023). 
https://doi.org/10.1126/sciadv.abo2467 
58 
Esteller, M. Epigenetics in cancer. N 
Engl J Med 358, 1148-1159 (2008). 
https://doi.org/10.1056/NEJMra072067 
59 
Chatterjee, A., Rodger, E. J. & Eccles, M. R. Epigenetic drivers of tumourigenesis and cancer 
metastasis. 
Semin 
Cancer 
Biol 
51, 
149-159 
(2018). 
https://doi.org/10.1016/j.semcancer.2017.08.004 
60 
Terekhanova, N. V. et al. Epigenetic regulation during cancer transitions across 11 tumour 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

types. Nature 623, 432-441 (2023). https://doi.org/10.1038/s41586-023-06682-5 
61 
Garcia-Alonso, L. et al. Single-cell roadmap of human gonadal development. Nature 607, 
540-547 (2022). https://doi.org/10.1038/s41586-022-04918-4 
62 
Hocker, J. D. et al. Cardiac cell type-specific gene regulatory programs and disease risk 
association. Sci Adv 7 (2021). https://doi.org/10.1126/sciadv.abf1444 
63 
Yoshimura, Y. et al. A single-cell multiomic analysis of kidney organoid differentiation. Proc 
Natl Acad Sci U S A 120, e2219699120 (2023). https://doi.org/10.1073/pnas.2219699120 
64 
Satpathy, A. T. et al. Massively parallel single-cell chromatin landscapes of human immune 
cell development and intratumoral T cell exhaustion. Nat Biotechnol 37, 925-936 (2019). 
https://doi.org/10.1038/s41587-019-0206-z 
65 
Wang, S. K. et al. Single-cell multiome of the human retina and deep learning nominate causal 
variants 
in 
complex 
eye 
diseases. 
Cell 
Genom 
2 
(2022). 
https://doi.org/10.1016/j.xgen.2022.100164 
66 
Jin, C. et al. The regulatory landscapes of human ovarian ageing. BioRxiv, 2022.2005. 
2018.492547 (2022).  
67 
Zhang, Z. et al. Single nucleus transcriptome and chromatin accessibility of postmortem 
human pituitaries reveal diverse stem cell regulatory mechanisms. Cell Rep 38, 110467 (2022). 
https://doi.org/10.1016/j.celrep.2022.110467 
68 
Muto, Y. et al. Single cell transcriptional and chromatin accessibility profiling redefine 
cellular heterogeneity in the adult human kidney. Nat Commun 12, 2190 (2021). 
https://doi.org/10.1038/s41467-021-22368-w 
69 
Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in 
mixed-phenotype 
acute 
leukemia. 
Nat 
Biotechnol 
37, 
1458-1465 
(2019). 
https://doi.org/10.1038/s41587-019-0332-7 
70 
Wang, J. et al. Single-cell multiomics of the human retina reveals hierarchical transcription 
factor collaboration in mediating cell type-specific effects of genetic variants on gene 
regulation. Genome Biol 24, 269 (2023). https://doi.org/10.1186/s13059-023-03111-8 
71 
Liang, Q. et al. A multi-omics atlas of the human retina at single-cell resolution. Cell Genom 3, 
100298 (2023). https://doi.org/10.1016/j.xgen.2023.100298 
72 
Herring, C. A. et al. Human prefrontal cortex gene regulatory dynamics from gestation to 
adulthood 
at 
single-cell 
resolution. 
Cell 
185, 
4428-4447 
e4428 
(2022). 
https://doi.org/10.1016/j.cell.2022.09.039 
73 
Ziffra, R. S. et al. Single-cell epigenomics reveals mechanisms of human cortical development. 
Nature 598, 205-213 (2021). https://doi.org/10.1038/s41586-021-03209-8 
74 
Corces, M. R. et al. Single-cell epigenomic analyses implicate candidate causal variants at 
inherited risk loci for Alzheimer's and Parkinson's diseases. Nat Genet 52, 1158-1168 (2020). 
https://doi.org/10.1038/s41588-020-00721-x 
75 
Morabito, S. et al. Single-nucleus chromatin accessibility and transcriptomic characterization 
of 
Alzheimer's 
disease. 
Nat 
Genet 
53, 
1143-1155 
(2021). 
https://doi.org/10.1038/s41588-021-00894-z 
76 
Ma, S. et al. Molecular and cellular evolution of the primate dorsolateral prefrontal cortex. 
Science 377, eabo7257 (2022). https://doi.org/10.1126/science.abo7257 
77 
Zhu, K. et al. Multi-omic profiling of the developing human cerebral cortex at the single-cell 
level. Sci Adv 9, eadg3754 (2023). https://doi.org/10.1126/sciadv.adg3754 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

78 
Trevino, A. E. et al. Chromatin and gene-regulatory dynamics of the developing human 
cerebral 
cortex 
at 
single-cell 
resolution. 
Cell 
184, 
5053-5069 
e5023 
(2021). 
https://doi.org/10.1016/j.cell.2021.07.039 
79 
Neural optimal transport predicts perturbation responses at the single-cell level. Nat Methods 
20, 1639-1640 (2023). https://doi.org/10.1038/s41592-023-01968-y 
80 
Buttner, M., Miao, Z., Wolf, F. A., Teichmann, S. A. & Theis, F. J. A test metric for assessing 
single-cell 
RNA-seq 
batch 
correction. 
Nat 
Methods 
16, 
43-49 
(2019). 
https://doi.org/10.1038/s41592-018-0254-1 
81 
Luecken, M. D. et al. Benchmarking atlas-level data integration in single-cell genomics. Nat 
Methods 19, 41-50 (2022). https://doi.org/10.1038/s41592-021-01336-8 
 
.
CC-BY-NC-ND 4.0 International license
available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint
this version posted December 21, 2024. 
; 
https://doi.org/10.1101/2024.12.19.629312
doi: 
bioRxiv preprint 

